Manulife (Manufacturers Life Insurance)’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-41,883
| Closed | -$4.49M | – | 3107 |
|
|
2023
Q1 | $4.49M | Buy |
41,883
+9,556
| +30% | +$1.03M | ﹤0.01% | 1140 |
|
|
2022
Q4 | $3.56M | Buy |
32,327
+16,120
| +99% | +$1.77M | ﹤0.01% | 1211 |
|
|
2022
Q3 | $950K | Buy |
16,207
+4,283
| +36% | +$251K | ﹤0.01% | 1629 |
|
|
2022
Q2 | $337K | Sell |
11,924
-119
| -1% | -$3.36K | ﹤0.01% | 2316 |
|
|
2022
Q1 | $455K | Sell |
12,043
-2,748
| -19% | -$104K | ﹤0.01% | 2264 |
|
|
2021
Q4 | $585 | Buy |
+14,791
| New | +$585 | ﹤0.01% | 2167 |
|